These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 18056893)

  • 61. Glycosylated hemoglobin level and number of oral antidiabetic drugs predict whether or not glycemic target is achieved in insulin-requiring type 2 diabetes.
    Lin SD; Tsai ST; Tu ST; Su CC; Chen JF; Lu CH; Wang CH; Yu NC; Hsu SR; Hsieh MC
    Prim Care Diabetes; 2015 Apr; 9(2):135-41. PubMed ID: 25266893
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cardiovascular events and all-cause mortality with insulin versus glucagon-like peptide-1 analogue in type 2 diabetes.
    Anyanwagu U; Mamza J; Mehta R; Donnelly R; Idris I
    Heart; 2016 Oct; 102(19):1581-7. PubMed ID: 27217068
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Hypoglycemia--simply annoying or dangerous?].
    Kern W
    MMW Fortschr Med; 2016 Jun; 158(11):67-70. PubMed ID: 27271419
    [No Abstract]   [Full Text] [Related]  

  • 64. Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes.
    Lipska KJ; Parker MM; Moffet HH; Huang ES; Karter AJ
    JAMA; 2018 Jul; 320(1):53-62. PubMed ID: 29936529
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
    Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK
    Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficacy and safety of Technosphere inhaled insulin compared with Technosphere powder placebo in insulin-naive type 2 diabetes suboptimally controlled with oral agents.
    Rosenstock J; Bergenstal R; Defronzo RA; Hirsch IB; Klonoff D; Boss AH; Kramer D; Petrucci R; Yu W; Levy B;
    Diabetes Care; 2008 Nov; 31(11):2177-82. PubMed ID: 18678610
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Characteristics associated with maintenance of mean A1C<6.5% in people with dysglycemia in the ORIGIN trial.
    ORIGIN Trial Investigators
    Diabetes Care; 2013 Oct; 36(10):2915-22. PubMed ID: 23656980
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Severe hypoglycemia is associated with antidiabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and dementia: results from the DIMORA study.
    Abbatecola AM; Bo M; Barbagallo M; Incalzi RA; Pilotto A; Bellelli G; Maggi S; Paolisso G;
    J Am Med Dir Assoc; 2015 Apr; 16(4):349.e7-12. PubMed ID: 25669671
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long).
    Zinman B; Philis-Tsimikas A; Cariou B; Handelsman Y; Rodbard HW; Johansen T; Endahl L; Mathieu C;
    Diabetes Care; 2012 Dec; 35(12):2464-71. PubMed ID: 23043166
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Improvement in glycemic control, cardiovascular risk factors and anthropometric data in type 2 diabetic patients after the switch from biphasic human insulin to biphasic premix analog insulin aspart].
    Gero L; Gyimesi A; Hidvégi T; Jánosi I
    Orv Hetil; 2009 Aug; 150(35):1637-47. PubMed ID: 19692308
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Older individuals with diabetes have an increased risk of recurrent falls: analysis of potential mediating factors: the Longitudinal Ageing Study Amsterdam.
    Pijpers E; Ferreira I; de Jongh RT; Deeg DJ; Lips P; Stehouwer CD; Nieuwenhuijzen Kruseman AC
    Age Ageing; 2012 May; 41(3):358-65. PubMed ID: 22156559
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical and Economic Outcomes Associated With the Timing of Initiation of Basal Insulin in Patients With Type 2 Diabetes Mellitus Previously Treated With Oral Antidiabetes Drugs.
    Levin P; Zhou S; Durden E; Farr AM; Gill J; Wei W
    Clin Ther; 2016 Jan; 38(1):110-21. PubMed ID: 26681210
    [TBL] [Abstract][Full Text] [Related]  

  • 73. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
    Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failure.
    Davidson MB; Raskin P; Tanenberg RJ; Vlajnic A; Hollander P
    Endocr Pract; 2011; 17(3):395-403. PubMed ID: 21324825
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes.
    Malone JK; Bai S; Campaigne BN; Reviriego J; Augendre-Ferrante B
    Diabet Med; 2005 Apr; 22(4):374-81. PubMed ID: 15787659
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Glycemic relapse in type 2 diabetes.
    Graber AL; Shintani AK; Wolff K; Brown A; Elasy TA
    Endocr Pract; 2006; 12(2):145-51. PubMed ID: 16690461
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Special considerations for the use of insulin in older adults.
    Dunican KC; Desilets AR
    Hosp Pract (1995); 2011 Feb; 39(1):22-9. PubMed ID: 21441755
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Improvement of glycemic control in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.
    Monami M; Candido R; Pintaudi B; Targher G; Mannucci E;
    Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2539-2546. PubMed ID: 34158243
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes.
    Hermansen K; Davies M; Derezinski T; Martinez Ravn G; Clauson P; Home P
    Diabetes Care; 2006 Jun; 29(6):1269-74. PubMed ID: 16732007
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of type 2 diabetes mellitus medication management and control in older adults.
    Thompson A; Vande Griend JP; Linnebur SA; Saseen JJ
    Consult Pharm; 2013 May; 28(5):296-306. PubMed ID: 23649678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.